Administration Report

Employees, research and development and environment

Employees
At the end of the financial year AddLife had 2,256 employees, compared with 2,301 at the beginning of the financial year. Completed acquisitions increased the number of employees by 13 (4). The average number of employees in 2024 was 2,311 (2,284).

Research and development
The Group conducts its own research and development to a limited extent, mainly within Biolin in the Labtech business area. In the Medtech business area, development work was carried out in the previous year on a digital platform in welfare technology within Camanio. At the end of 2023, a decision was taken to close the company. During 2024, active efforts were made to help existing customers migrate to alternative solutions, and in the third quarter of 2024 the closure of Camanio's operations was completed. 

Environment
None of the Group’s Swedish subsidiaries engage in activities that require a permit or notification under the Swedish Environmental Code. None of the foreign subsidiaries engage in activities subject to equivalent requirements for notification or permits. None of the Group’s companies are engaged in any environment-related disputes.